Cancer

INDICATION: Chronic myelogenous leukemia (CML)

Patient sample, cell culture and mouse studies suggest combining ribosomal 30S subunit inhibitors or other inhibitors

Read the full 213 word article

How to gain access

Continue reading with a
two-week free trial.